FPR Criteria | FPR = 10 | FPR = 5.75 | ||||
---|---|---|---|---|---|---|
Patient characteristics | CXCR4 (n=44), n (row %) | R5 (n=66), n (row %) | P-value | CXCR4 (n=35), n (row %) | R5 (n=75), n (row %) | P-value |
Median age (median, IQR) | 36.9 [28.8–45.4] | 36.4 [27.6–44.6] | 0.665 | 39.7 [29.4–45.4] | 35.6 [27.6–45.0] | 0.539 |
Male gender | 38 (39.1) | 59 (61.0) | 0.765 | 30 (30.9) | 67 (69.1) | 0.752 |
Ethnicity | ||||||
Chinese | 34 (77.3) | 54 (81.8) | 0.630 | 27 (77.1) | 61 (81.3) | 0.617 |
Non-Chinese | 10 (22.7) | 12 (18.2) | 8 (22.9) | 14 (18.7) | ||
Transmission risk | ||||||
Heterosexual | 20 (45.5) | 30 (45.5) | 0.945 | 15 (42.9) | 36 (48.0) | 0.502 |
MSM | 23 (52.3) | 33 (50.0) | 14 (40.0) | 32 (42.7) | ||
Othersa | 1 (3.0) | 3 (4.5) | 6 (17.1) | 7 (9.3) | ||
CD4 count at presentation (median, IQR) | 226 [32–402] | 333 [200–462] | 0.013 | 219 [35–336] | 333 [189–470] | 0.025 |
Evidence of recent seroconversion(n=25) | ||||||
Subtype B | 2 (8.0) | 4 (16.0) | 0.011 | 1 (4.0) | 5 (20.0) | 0.007 |
CRF01_AE | 3 (12.0) | 10 (40.0) | 3 (12.0) | 10 (40.0) | ||
CRF51_01B | 5 (2.0) | 0 (0.0) | 5 (20.0) | 0 (0.0) | ||
Othersc | 0 (0.0) | 1 (4.0) | 0 (0.0) | 1 (4.0) |